L. rhamnosus GR-1 and L. reuteri RC-14 and vaginal flora

What 2 graded rows on l. rhamnosus gr-1 and l. reuteri rc-14 agree on for vaginal flora, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the L. rhamnosus GR-1 and L. reuteri RC-14 page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the L. rhamnosus GR-1 and L. reuteri RC-14 page, with its PubMed record.

Supplement

L. rhamnosus GR-1 and L. reuteri RC-14 Choose another

2 rows · 136 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a randomized trial of 72 people (2008) and found an improvement.

The rows run from 64 to 72 people, published from 2003 to 2008: 2 single studies.

2 improved

Grade CVaginal flora after menopause · Improved
RCT · n 72 · 2008 · 72 postmenopausal women with intermediate Nugent scores (4 to 6)
2.5 billion CFU of each strain once daily · 14 days
Nugent score improved by at least two grades in 21 of 35 (60%) on probiotic vs 6 of 37 (16%) on placebo (p=0.0001).
Row on the L. rhamnosus GR-1 and L. reuteri RC-14 page · PubMed 18701205 (opens PubMed)
Grade CVaginal flora in healthy women · Improved
RCT · n 64 · 2003 · 64 healthy women
Daily capsules (CFU not stated in the abstract) · 60 days
Microscopy showed a shift from asymptomatic bacterial vaginosis flora to normal lactobacilli flora in 37% of women on lactobacilli vs 13% on placebo (P=0.02); yeast and coliforms fell in the probiotic group; no adverse effects.
Row on the L. rhamnosus GR-1 and L. reuteri RC-14 page · PubMed 12628548 (opens PubMed)